Dario Arnaldi
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 213 publications
Structural MRI signature predicts tau staging in Alzheimer's disease.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: May 08, 2026
Correction to: Head to head comparison between arterial spin labelling MRI and [18F]FDG-PET in presurgical evaluation of epilepsy in children: the role of voxel-based asymmetry index analysis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 26, 2026
Daridorexant: exploring its role in the treatment of insomnia disorder.
Journal: Expert review of neurotherapeutics
Published: March 12, 2026
A gradual and sustainable approach to diagnosing sleep and circadian disturbances in dementia.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 26, 2026
Exploring the spatial covariance of cerebral vascular density and amyloid burden in Alzheimer's disease.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: February 15, 2026
Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026
Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026
Daridorexant Treatment for Chronic Insomnia in Restless Legs Syndrome.
Journal: Movement disorders clinical practice
Published: February 09, 2026
Glymphatic clearance as revealed by diffusion tensor imaging along the perivascular space (DTI-ALPS) is associated with Alzheimer's disease neuropathology and periodic rsEEG alpha rhythms in mild cognitive impairment participants.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: January 27, 2026
Neuroimaging and Pathology Biomarkers in Parkinson's Disease and Parkinsonism.
Journal: Brain sciences
Published: December 24, 2025
Abnormal periodic and aperiodic resting-state electroencephalographic markers in Lewy body and Alzheimer's diseases with cognitive decline.
Journal: GeroScience
Published: December 18, 2025
MRI susceptibility map weighted imaging (SMWI) as a neurodegeneration biomarker in the prodromal to overt alpha-synucleinopathy continuum.
Journal: Journal of Parkinson's disease
Published: December 03, 2025
Last Updated: 09/26/2026